Nakamura Y
Third Department of Internal Medicine, Hokkaido University School of Medicine, Sapporo, Japan.
Hokkaido Igaku Zasshi. 1998 Sep;73(5):505-17.
Mutation in the p53 tumor suppressor gene is known to play a critical role in the carcinogenesis of many types of human cancers, especially in colon carcinogenesis. To investigate the early stage of neoplastic processes, a simple and reliable method is needed to evaluate the state of p53 mutation. For this purpose, we tested the availability of the recently developed yeast functional assay to minute endoscopic samples. The assay consisted of 3 steps: 1) extraction of mRNA from the minute samples, 2) reverse transcriptional polymerase chain reaction (RT-PCR) amplification of the mRNA, and 3) transformation of yeasts by means of crude PCR products. This was an effective way to analyze many samples within a short period of time (2 days). The results were visible either as white colonies (wild type) or red colonies (mutant type). At first, we tested whether the quantity of mutants was measurable or not by analyzing a calibrated mixture of the cells known to harbor mutant and wild-type. The percentage of the red colonies that showed mutant p53 alleles was in proportion to the initial input percentage of the mutant p53 cells. Secondly, in clinical cases, it was found that minute samples (10-20 mg) were sufficient both for the analysis of yeast functional assays and pathologic examinations. The samples taken from normal mucosa and adenomas revealed fewer red colonies than the background value of this assay (10%). All the samples from adenocarcinomas yielded red colonies over 20%. The percentage of red colonies was well consistent with the ratio of cancer cell numbers to total cells. However, the percentage was not always correlated with the number of immunohistochemically positive cells stained with monoclonal antibody to detect abnormal p53. These results indicate that this assay combined with histological examination may provide useful information on determining carcinogenesis in endoscopic samples.
已知p53肿瘤抑制基因的突变在多种人类癌症的致癌过程中起着关键作用,尤其是在结肠癌的致癌过程中。为了研究肿瘤形成过程的早期阶段,需要一种简单可靠的方法来评估p53突变状态。为此,我们测试了最近开发的酵母功能测定法对微小内镜样本的适用性。该测定法包括3个步骤:1)从微小样本中提取mRNA;2)对mRNA进行逆转录聚合酶链反应(RT-PCR)扩增;3)用粗制PCR产物转化酵母。这是在短时间内(2天)分析多个样本的有效方法。结果以白色菌落(野生型)或红色菌落(突变型)可见。首先,我们通过分析已知含有突变型和野生型细胞的校准混合物,测试了突变体数量是否可测。显示突变型p53等位基因的红色菌落百分比与突变型p53细胞的初始输入百分比成正比。其次,在临床病例中,发现微小样本(10 - 20毫克)足以用于酵母功能测定分析和病理检查。从正常黏膜和腺瘤中获取的样本显示红色菌落比该测定法的背景值(10%)少。所有来自腺癌的样本产生的红色菌落超过20%。红色菌落百分比与癌细胞数量与总细胞数量的比例高度一致。然而,该百分比并不总是与用单克隆抗体检测异常p53染色的免疫组化阳性细胞数量相关。这些结果表明,该测定法与组织学检查相结合可能为确定内镜样本中的致癌作用提供有用信息。